Ryan, C., Wang, V., Smith, M., Till, B., Parekh, S., Yang, D., Kostakoglu, L., Samad, N. A., Jegede, O., Little, R., Friedberg, J., Leonard, J., Kahl, B., Martin, P. (2025). Prognostic impact of Mantle Cell Lymphoma frontline induction response assessments in the ECOG-ACRIN E1411 study of bendamustine-rituximab +/- bortezomib and maintenance with rituximab +/- lenalidomide. Blood. https://doi.org/10.1182/blood-2025-3581